- 期刊
Comorbidities and Concomitant Medication Use in Men with Prostate Cancer or High Levels of PSA Compared to Matched Controls: A GPRD Analysis
延伸閱讀
- Fang, M., Nakazawa, M., Antonarakis, E. S., & Li, C. (2017). Efficacy of Abiraterone and Enzalutamide in Pre- and Postdocetaxel Castration-Resistant Prostate Cancer: A Trial-Level Meta-Analysis. Prostate Cancer, 2017(), 1-8-003. https://doi.org/10.1155/2017/8560827
- Chandra, R. A., Chen, M. H., Zhang, D., Loffredo, M., & D'Amico, A. V. (2014). Evidence Suggesting That Obesity Prevention Measures May Improve Prostate Cancer Outcomes Using Data from a Prospective Randomized Trial. Prostate Cancer, (2014), 92-97. https://doi.org/10.1155/2014/478983
- Selli, C., Bjartell, A., Burgos, J., Somerville, M., Palacios, J. M., Benjamin, L., Black, L., & Castro, R. (2014). Burden of Illness in Prostate Cancer Patients with a Low-to-Moderate Risk of Progression: A One-Year, Pan-European Observational Study. Prostate Cancer, (2014), 84-91. https://doi.org/10.1155/2014/472949
- 袁得峻（2015）。The Association Between Complications after The Adoption of Different Operations and Preoperative Comorbidities for Benign Prostate Hyperplasia Patients〔碩士論文，國立中正大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0033-2110201614005548
- 盧致誠、陸言、袁得峻（2017）。The association between complications after the adoption of different operations and preoperative comorbidities for benign prostate hyperplasia patients。醫療資訊雜誌，26(2)，1-15+17-20+22。https://www.airitilibrary.com/Article/Detail?DocID=10213155-201706-201711010014-201711010014-1-15+17-20+22